Biliary excretion of cefaclor. Experimental and clinical study

Area of Science:

• Pharmacology
• Hepatobiliary Science
• Antibiotic Research

Background:

• Cephalosporins are widely used antibiotics.
• Understanding drug excretion pathways is crucial for optimizing therapy.
• Biliary excretion of cefaclor, a new oral cephalosporin, requires investigation.

Purpose of the Study:

• To investigate the biliary excretion of cefaclor in vitro using a rabbit liver model.
• To determine cefaclor's biliary excretion and concentration in human patients post-oral administration.
• To compare cefaclor's biliary excretion with other cephalosporins.

Main Methods:

• In vitro perfusion of isolated rabbit liver with cefaclor.
• Oral administration of cefaclor to cholecystectomized human patients with T tubes.
• Measurement of cefaclor concentrations in serum and bile samples.

Main Results:

• In rabbits, 2.3% of cefaclor dose was recovered in bile.
• In humans, mean peak biliary concentration was 7.6 µg/ml at 3 hours, with 0.05% cumulative excretion.
• Serum and bile concentrations were measured in patients during cholecystectomy.

Conclusions:

• Cefaclor exhibits low biliary excretion in both experimental models and human subjects.
• The findings suggest limited hepatic and biliary elimination of cefaclor.
• Further studies are needed to compare cefaclor's biliary excretion profile with other cephalosporins.